These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


110 related items for PubMed ID: 9675101

  • 21. A novel bispecific antisense oligonucleotide inhibiting both bcl-2 and bcl-xL expression efficiently induces apoptosis in tumor cells.
    Zangemeister-Wittke U, Leech SH, Olie RA, Simões-Wüst AP, Gautschi O, Luedke GH, Natt F, Häner R, Martin P, Hall J, Nalin CM, Stahel RA.
    Clin Cancer Res; 2000 Jun; 6(6):2547-55. PubMed ID: 10873111
    [Abstract] [Full Text] [Related]

  • 22. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
    Henkels KM, Turchi JJ.
    Cancer Res; 1999 Jul 01; 59(13):3077-83. PubMed ID: 10397248
    [Abstract] [Full Text] [Related]

  • 23. Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1.
    Chau BN, Cheng EH, Kerr DA, Hardwick JM.
    Mol Cell; 2000 Jul 01; 6(1):31-40. PubMed ID: 10949025
    [Abstract] [Full Text] [Related]

  • 24. Membrane-insertion fragments of Bcl-xL, Bax, and Bid.
    García-Sáez AJ, Mingarro I, Pérez-Payá E, Salgado J.
    Biochemistry; 2004 Aug 31; 43(34):10930-43. PubMed ID: 15323553
    [Abstract] [Full Text] [Related]

  • 25. Analysis of apoptosis and expression of bcl-2 gene family members in the human and baboon ovary.
    Kugu K, Ratts VS, Piquette GN, Tilly KI, Tao XJ, Martimbeau S, Aberdeen GW, Krajewski S, Reed JC, Pepe GJ, Albrecht ED, Tilly JL.
    Cell Death Differ; 1998 Jan 31; 5(1):67-76. PubMed ID: 10200447
    [Abstract] [Full Text] [Related]

  • 26. Bcl-xES, a BH4- and BH2-containing antiapoptotic protein, delays Bax oligomer formation and binds Apaf-1, blocking procaspase-9 activation.
    Schmitt E, Paquet C, Beauchemin M, Bertrand R.
    Oncogene; 2004 May 13; 23(22):3915-31. PubMed ID: 15048082
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes].
    Zhang DL, Ji L, Li YD.
    Yi Chuan Xue Bao; 2004 May 13; 31(5):431-43. PubMed ID: 15478601
    [Abstract] [Full Text] [Related]

  • 29. Differential expression of bcl-2 and bcl-x during chicken spermatogenesis.
    Vilagrasa X, Mezquita C, Mezquita J.
    Mol Reprod Dev; 1997 May 13; 47(1):26-9. PubMed ID: 9110311
    [Abstract] [Full Text] [Related]

  • 30. A novel Bcl-x splice product, Bcl-xAK, triggers apoptosis in human melanoma cells without BH3 domain.
    Hossini AM, Geilen CC, Fecker LF, Daniel PT, Eberle J.
    Oncogene; 2006 Apr 06; 25(15):2160-9. PubMed ID: 16288206
    [Abstract] [Full Text] [Related]

  • 31. Taxol and estramustine-induced modulation of human prostate cancer cell apoptosis via alteration in bcl-xL and bak expression.
    Liu QY, Stein CA.
    Clin Cancer Res; 1997 Nov 06; 3(11):2039-46. PubMed ID: 9815595
    [Abstract] [Full Text] [Related]

  • 32. Significant augmentation of pro-apoptotic gene therapy by pharmacologic bcl-xl down-regulation in mesothelioma.
    Mohiuddin I, Cao X, Fang B, Nishizaki M, Smythe WR.
    Cancer Gene Ther; 2001 Aug 06; 8(8):547-54. PubMed ID: 11571532
    [Abstract] [Full Text] [Related]

  • 33. LPA protects intestinal epithelial cells from apoptosis by inhibiting the mitochondrial pathway.
    Deng W, Wang DA, Gosmanova E, Johnson LR, Tigyi G.
    Am J Physiol Gastrointest Liver Physiol; 2003 May 06; 284(5):G821-9. PubMed ID: 12684213
    [Abstract] [Full Text] [Related]

  • 34. Genomic profiling of acquired resistance to apoptosis in cells derived from human atherosclerotic lesions: potential role of STATs, cyclinD1, BAD, and Bcl-XL.
    Gagarin D, Yang Z, Butler J, Wimmer M, Du B, Cahan P, McCaffrey TA.
    J Mol Cell Cardiol; 2005 Sep 06; 39(3):453-65. PubMed ID: 16005468
    [Abstract] [Full Text] [Related]

  • 35. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.
    Fang G, Chang BS, Kim CN, Perkins C, Thompson CB, Bhalla KN.
    Cancer Res; 1998 Aug 01; 58(15):3202-8. PubMed ID: 9699642
    [Abstract] [Full Text] [Related]

  • 36. MCL-1V, a novel mouse antiapoptotic MCL-1 variant, generated by RNA splicing at a non-canonical splicing pair.
    Kojima S, Hyakutake A, Koshikawa N, Nakagawara A, Takenaga K.
    Biochem Biophys Res Commun; 2010 Jan 01; 391(1):492-7. PubMed ID: 19919825
    [Abstract] [Full Text] [Related]

  • 37. Presence of the long and the short forms of Bcl-X in several human and murine tissues.
    Rouayrenc JF, Boise LH, Thompson CB, Privat A, Patey G.
    C R Acad Sci III; 1995 May 01; 318(5):537-40. PubMed ID: 7670999
    [Abstract] [Full Text] [Related]

  • 38. Identification of a novel Bcl-2 related gene, BRAG-1, in human glioma.
    Das R, Reddy EP, Chatterjee D, Andrews DW.
    Oncogene; 1996 Mar 07; 12(5):947-51. PubMed ID: 8649811
    [Abstract] [Full Text] [Related]

  • 39. Bcl-X is the major pleiotropic anti-apoptotic gene activated by retroviral insertion mutagenesis in an IL-3 dependent bone marrow derived cell line.
    Thomas J, Leverrier Y, Marvel J.
    Oncogene; 1998 Mar 07; 16(11):1399-408. PubMed ID: 9525739
    [Abstract] [Full Text] [Related]

  • 40. Increased ratio of bcl-2/bax expression is associated with bovine leukemia virus-induced leukemogenesis in cattle.
    Reyes RA, Cockerell GL.
    Virology; 1998 Mar 01; 242(1):184-92. PubMed ID: 9501056
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.